Neuren Pharmaceuticals Limited (ASX: NEU)
Neuren Pharmaceuticals Limited (ASX: NEU) is into biopharmaceutical sector. It is into the development of new therapies for brain injury, and disorders related to neurodevelopment and neurodegenerations. The company emphasizes on several product development opportunities with several important factors.
The company in the recent past has reported that the period of exclusive negotiation with ACADIA Pharmaceuticals to achieve the rights to develop and commercialize trofinetide for territories outside North America has ended on 31 January 2019. The Board of the company has determined the offer not be in the best interests of shareholders of the company.
At the time of writing (4 February 2019, AEST 12:58 PM), the stock of Neuren Pharmaceuticals is trading at $1.235, with a market capitalization of $129.36 million. It has generated a negative YTD return of 17.65% and posted negative returns of 53.33% and 17.65% over the last six months, and the one-month period respectively. It has a 52-week high price of $3.60 and a 52-week low of $1.005, with an average trading volume of ~65,784.
Alliance Mineral Assets Limited (ASX: A40)
Alliance Mineral Assets Limited (ASX: A40) is into the production of lithium concentrate in Bald Hill Lithium and Tantalum Mine, that is the principal project of the company. The Bald Hill spodumene mine is wholly owned by the company. It had a merger with its JV partner Tawana Resources. The production of commercial lithium concentrate has been started by the Bald Hill Mine in July 2018.
The company in the recent past had released quarterly report for the period ended 31 December 2018 where it reported a net cash outflow from operating activities of $A13,256,000 for the quarter. The cash inflow from investing and financing activities, however, stood at $A1,594,000 and $A13,310,000 for the quarter respectively. As at 31 December 2018, the company had cash and cash equivalent of $13,054,000.
The stock of Alliance Mineral is currently trading at a price of $0.170, with a market capitalization of $208.85 million (4 February 2019, AEST 12:58 PM). It has a 52-week high price of $0.330 and a 52-week low of $0.155, with an average trading volume of approximately 1,854,708.
AVZ Minerals Limited (ASX: AVZ)
AVZ Minerals Limited (ASX: AVZ) is into the exploration of minerals. The exploration operations of the company are concentrated in Namibia, with the company holding an interest in several mineral exploration projects including the lithium-rich Manono project.
The company in the recent past has made the announcement for the new issue of shares worth $10 million at an issue price of twenty percent discount to the VWAP for shares, 15 million options to acquire the shares, and up to $5 million worth of shares at the issue price. Moreover, the company has reported its robust results from the Mineral Resource drilling at the Manono Lithium and Tin Project.
At the time of writing (4 February 2019 AEST 1:24 PM), the stock of AVZ Minerals is trading at $0.050, with a market capitalization of $92.53 million. It has generated a negative YTD return of 33.78% and posted negative returns of 62.31%, 23.44% and 33.78% over the last six months, three months and one-month period respectively. It has a 52-week high price of $0.330 and a 52-week low of $0.043, with an average trading volume of ~ 5,723,747.
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.